The Possible Role of Immunotherapy in Locally Advanced Pancreatic Cancer Treatment
LAPC remains one of the deadliest malignancies, with immunotherapy offering potential but constrained by limited survival benefits and adverse effects. Further studies focusing on novel agents, refined combinations, and overcoming tumor resistance mechanisms are critical to improve outcomes for this challenging disease.
Authors
- Athanasios Stavropoulos (ORCID: https://orcid.org/0000-0002-5101-1899)
- Dimitrios Filippou (ORCID: https://orcid.org/0000-0001-5410-3046)
- Rouan Barakat
- Andreas Palantzas
- Despoina Sidira
- Nikias Konsolas
Institutions
- Technological Educational Institute of Piraeus (GR)
- National and Kapodistrian University of Athens (GR)
Publication Details
- Journal
- Acta Medica Academica
- Published
- 2025-08-25
- DOI
- https://doi.org/10.5644/ama2006-124.479
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05